Search:
Filter:
Sort:
The med spa owner admitted to using unapproved injectables that sickened at least 10 patients. New York authorities announced the results of a 2024 crackdown on illegal med spas. PSM published in The Journal of Illicit Trade, Financial Crime, and Compliance.
Read More
PSM wrote the House Energy & Commerce Committee in support of the Safeguarding Americans from Fraudulent and Experimental (SAFE) Drugs Act, to help protect the American drug supply from unsafely compounded medication.
Read More
FDA announced the seizure of dozens of counterfeit Ozempic 1mg injection pens labeled with an authentic lot number, PAR1229, but displaying the expiration and lot numbers for the product in the wrong place.
Read More
The FDA and Novo Nordisk are warning the public about counterfeit Ozempic injections circulating in the legitimate U.S. drug supply chain. The FDA announced the seizure of multiple batches of counterfeit Ozempic 1 mg injections, labeled with lot number PAR1229, on December 5, 2025. Their contents and safety are unverified and pose serious health risks.
Read More
Since 2019, federal prosecutors, drug manufacturers, and patient safety organizations have uncovered extensive criminal schemes targeting HIV medicines at every point in the supply chain. These schemes undermine trust in the healthcare system, and they endanger patients.
Read More
Prescription Drug Affordability Board Activity, October 2025 Activities Summary Colorado: Colorado’s PDAB heard testimony about its decision to set an upper payment limit on Enbrel, and set price of $600 per 50mg/1ml, effective January 1, 2027. The board’s next meeting was rescheduled from November 14, 2025 to January 9, 2026. Maryland: The PDAB will next meet November 17, 2025. Oregon:…
Read More
MMWR field notes about Americans hospitalized after self-injecting imported Botox raise serious concerns about patient safety.
Read More
Surveys document consumer behaviors when purchasing medication from online pharmacies, finding that the public may not be aware of the dangers of IOPs.
Read More
What are the most important lessons from CNBC’s documentary about alternative funding programs (AFPs)?
Read More
CNBC aired a documentary about alternative funding programs that included interviews with PSM’s Shabbir Imber Safdar, HSI and FDA officials, as well as a representative from Gilead Sciences and from the companies supplying these drug.
Read More